Comorbidities recorded at registry inclusion.
Comorbid condition, n (%) | N=277 |
Gastrointestinal disorders | 139 (50.2) |
Gastro-oesophageal reflux disease | 131 (47.3) |
Metabolism and nutrition disorders | 110 (39.7) |
Hypercholesterolaemia | 68 (24.6) |
Diabetes mellitus | 42 (15.2) |
Vascular disorders | 105 (37.9) |
Hypertension | 92 (33.2) |
Cardiac disorders | 77 (27.8) |
Respiratory, thoracic and mediastinal disorders | 55 (19.9) |
Pulmonary hypertension* | 11 (4.0) |
Emphysema | 11 (4.0) |
Acute exacerbations* | 3 (1.1) |
Musculoskeletal disorders | 52 (18.8) |
Infections and infestations | 43 (15.5) |
Pneumonia | 13 (4.7) |
Sinusitis | 5 (1.8) |
Neoplasms benign, malignant and unspecified (including cysts and polyps) | 33 (11.9) |
Non-small cell malignant neoplasms of the respiratory tract cell-type specified | 3 (1.1) |
Respiratory tract and pleural neoplasms cell-type unspecified | 1 (0.4) |
Nervous system disorders | 33 (11.9) |
Psychiatric disorders | 33 (11.9) |
Depression | 15 (5.4) |
*Collected as ‘IPF-related comorbidities’ at the inclusion visit.
IPF, idiopathic pulmonary fibrosis.